Curtis Dunshee

Gustave Roussy Research Shares a Study on TALAPRO-2 as a New Standard of Care in mCRPC

Karen Knudsen: Science in Action – Men with Advanced Prostate Cancer Benefit

Miguel Bronchud: Prostate Cancer Treatments Continue to Evolve

TALAPRO-2: Miloš Grujić highlights improved quality of life with Talazoparib + Enzalutamide in mCRPC

TALAPRO-2 Trial: First-line talazoparib plus enzalutamide VS placebo plus enzalutamide in prostate cancer – Mirrors of Medicine

Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC